1. REPORT
2. ESAP METADATE
3. INFORMATION ABOUT THE ENTITY
4. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
POLISH FINANCIAL SUPERVISION AUTHORITY |
|||||||||||
|
UNI - EN REPORT No |
51 | / |
2026 |
|
||||||
Date of issue: |
2026-11-18 |
||||||||||
Short name of the issuer |
|||||||||||
KRKA |
|||||||||||
Subject |
|||||||||||
Share buy-back programme schedule from January to June 2027 |
|||||||||||
Official market - legal basis |
|||||||||||
Unofficial market - legal basis |
|||||||||||
Contents of the report: |
|||||||||||
Based on the provisions of Article 26 of the Ljubljana Stock Exchange Rules, Article 158 of the Market in Financial Instruments Act, Article 2 of the Commission Delegated regulation (EU) No 2016/1052 and Article 17 of Regulation (EU) No 596/2014, Krka, d. d., Novo mesto (hereinafter: Krka) discloses information regarding share buy-back programme schedule from January to June 2027. Krka disclosed the start of the share buy-back programme on 20 July 2026 through the electronic dissemination system SEOnet. The programme schedule for H1 2027 is attached. The public will be regularly informed about these acquisitions of treasury shares. This announcement will be published on the company’s website (www.krka.biz) starting from 18 November 2026 for a minimum period of 5 years. |
|||||||||||
Annexes |
|||||||||||
File |
Description |
||||||||||
Share buy-back programme schedule from January to June 2027.pdf |
Share buy-back programme schedule from January to June 2027 |
||||||||||
Legal framework |
Type of information |
||||
TRANSD |
Acquisition or disposal of an issuer’s own shares |
||||
RegulatoryData |
|||||
Collection Body |
PLKNF |
||||
Unique data record identifier |
|||||
Type of submission |
New (to be used for new information) |
||||
Voluntary information flag |
|||||
Date or period covered [Date or beginning of the period to which the information relates] |
2027-01-01 |
||||
Date or period covered [Date or end of the period to which the information relates] |
2027-06-30 |
||||
Personal data flag |
|||||
Macierzyste państwo członkowskie, w stosownych przypadkach |
PL |
||||
DocumentReference |
|||||
Język, w którym przekazano informacje |
Oryginał (ORIG) czy tłumaczenie (TRAN) |
Numer referencyjny pliku danych |
|||
PL |
ORIG |
||||
SubmittingEntity |
|||||
Submitting entity LEI |
or |
Submitting entity name - natural person |
|||
RelatedEntity/LegalPerson |
|||||
Entity LEI |
Size of the entity |
Industry sector(s) |
|||
549300H9RLRTRTLRUZ73 |
Large group |
(acc. NACE): C |
|||
KRKA, TOVARNA ZDRAVIL D.D. |
|||||||||||||
(fullname of the issuer) |
|||||||||||||
KRKA |
Farmaceutyczny (far) |
||||||||||||
(short name of the issuer) |
(sector according to clasification of the WSE in Warsow) |
||||||||||||
8501 |
Nove Mesto |
||||||||||||
(post code) |
(city) |
||||||||||||
Smarjeska |
6 | ||||||||||||
(street) |
(number) |
||||||||||||
+386 7 331 21 11 |
+386 7 332 15 37 |
||||||||||||
(phone number) |
(fax) |
||||||||||||
(e-mail) |
(web site) |
||||||||||||
nie dotyczy |
|||||||||||||
(NIP) |
(REGON) |
||||||||||||
SIGNATURE OF PERSONS REPRESENTING THE COMPANY |
|||||
Date |
Name |
Position / Function |
Signature |
||
2026-11-18 |
Jože Colarič |
President of the Management Board and CEO |
|||
































































